Pedroli G L, Garweg J G, Imesch P, Böhnke M
Universitäts-Augenklinik, Inselspital, Bern.
Klin Monbl Augenheilkd. 1998 May;212(5):353-5. doi: 10.1055/s-2008-1034904.
Necrotizing retinopathies of suspected viral origin, but which do not meet the criteria for either CMV-retinitis or acute retinal necrosis syndrome, have been grouped together under the term atypical necrotizing retinopathies. Nothing is known about their etiology.
Aqueous humor samples were drawn from two HIV-positive and eight patients with AIDS presenting with an atypical necrotizing retinopathy, additionally from six patients with acute retinal necrosis syndrome and 28 patients with active CMV-retinitis at the time of diagnosis as well as from thirty healthy controls at surgery. All samples underwent DNA extraction and amplification for viral DNA of HSV-1, VZV and CMV.
VZV-DNA was detected in seven of nine aqueous humor samples derived from patients with atypical necrotizing retinopathies and in four of six samples from patients with acute retinal necrosis syndrome, but not in any one from the 28 patients with CMV retinitis. In the latter group, CMV DNA was detectable in 23 samples, in two of these additionally HSV-1 DNA. No viral DNA was amplified from any of the samples from healthy controls.
Varicella zoster virus ist the leading cause of atypical necrotizing retinopathies. This should be considered in the antiviral chemotherapy. Moreover, we were able to establish the diagnosis using DNA amplification for the viruses of the herpes family irrespective of the etiology in 80% of necrotizing retinopathies.
疑似病毒起源的坏死性视网膜病变,但不符合巨细胞病毒性视网膜炎或急性视网膜坏死综合征的标准,已被归为非典型坏死性视网膜病变。对其病因尚不清楚。
从两名HIV阳性患者和八名患有非典型坏死性视网膜病变的艾滋病患者中抽取房水样本,另外从六名急性视网膜坏死综合征患者和28名诊断时患有活动性巨细胞病毒性视网膜炎的患者以及30名手术时的健康对照者中抽取房水样本。所有样本均进行DNA提取和针对单纯疱疹病毒1型、水痘带状疱疹病毒和巨细胞病毒的病毒DNA扩增。
在九份来自非典型坏死性视网膜病变患者的房水样本中的七份以及六份来自急性视网膜坏死综合征患者的样本中的四份中检测到水痘带状疱疹病毒DNA,但在28名巨细胞病毒性视网膜炎患者的样本中均未检测到。在后者组中,23份样本中可检测到巨细胞病毒DNA,其中两份还检测到单纯疱疹病毒1型DNA。健康对照者的任何样本中均未扩增出病毒DNA。
水痘带状疱疹病毒是非典型坏死性视网膜病变的主要病因。在抗病毒化疗中应予以考虑。此外,我们能够通过对疱疹家族病毒进行DNA扩增来确诊80%的坏死性视网膜病变,而不论其病因如何。